在冠状动脉血管形成术后,普鲁科尔对血管重塑的影响. 多种维生素和协议研究小组研究小组
G Côté1, J C Tardif, J Lespérance
1Department of Medicine, Montreal Heart Institute, Montreal, Canada.
Circulation
|January 13, 1999
概括
普罗布科尔改善了气球血管造形术后的血管改造,减少了复缩. 这项研究使用了血管内超声波 (IVUS) 来证明试管节.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 之前的研究表明,probucol可以降低血管造形术后的复原.
- 血管造影不足以确定probucol是否防止了新阴位的形成或改善了血管重塑.
- 血管内超声波 (IVUS) 是必要的,以区分这些影响.
研究的目的:
- 为了研究probucol在气球血管造形术后减少静脉缩的机制.
- 为了确定probucol的效果是由于防止neointimal形成或增强血管改造.
- 使用IVUS进行血管变化的详细分析.
主要方法:
- 一项随机试验,涉及317名接受气球血管整形手术的患者.
- 患者在血管造形术后6个月接受了普鲁科尔,多种维生素,联合治疗或安慰剂.
- 血管内超声波 (IVUS) 在血管塑性手术后立即进行,并在94名患者的随访中进行.
主要成果:
- 照明面积在安慰剂组下降,变化与外弹性膜 (EEM) 面积比壁面积更相关.
- 与安慰剂 (-1.21 mm2) 相比,Probucol 单独显示出明显减少光损失 (-0.15 mm2).
- 普罗布科尔治疗导致EME面积显著增加 (1.74毫米2),表明血管重塑得到改善.
结论:
- 血管塑造术后的光层损失是由于对新极限形成的反应而造成的血管改造不足.
- 普罗布科尔有效地改善了血管改造,从而发挥了其抗缩作用.
- IVUS分析证实了probucol对血管重塑机制的有益影响.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...